Comin Instruments’ August revenue increased by 15.4% year-on-year, and the installed capacity of femtosecond cataract equipment increased

Jiang Jinxian, Chairman of Comin Instruments.

Comin Instruments (7881), a major manufacturer of ophthalmic cataract equipment in Xingcai, announced August revenue of 54.43 million yuan, a monthly decrease of 22% and an annual increase of 15.4%. Benefiting from the increase in the installed capacity of large-scale surgical equipment and the substantial promotion of the new product short-focus intraocular lenses, this year's performance growth momentum will be increased.

Jiang Jinxian, Chairman of Comin, pointed out that the penetration rate of the company's femtosecond cataract equipment continues to rise, and the equipment leasing business with small and medium-sized eye clinics continues to maintain a high level. Through the leasing and billing model, the volume of surgeries and consumable sales have increased, laying the foundation for the market share of femtosecond cataract equipment and consumables to reach 46% and 43.3% respectively.

The large-scale surgical equipment recently purchased by Comin Medical Center has been completed for acceptance and installation. Following the recent successful entry into the Rongzong system, the sales volume of the Z8 (Ziemer) femtosecond cataract equipment, which sells for tens of millions per unit, has increased to 5 units as of August, a significant increase of 2 units compared with the same period last year. In view of the annual peak of the cataract surgery season during the Lunar New Year, the installed capacity of Z8 (Ziemer) in September will continue to grow compared with August, supporting stronger operations.

Jiang Jinxian said that in addition to the continuous increase in the penetration rate of femtosecond cataract equipment, Comin's intraocular lens business has also continued to grow. In particular, the demand for HOYA trifocal intraocular lenses, which are specially designed for cataract and presbyopia patients, has increased, driving the company's overall intraocular lens average selling price (ASP). In addition, the newly launched short telefocal intraocular lenses have been widely promoted in major ophthalmology institutions since October, adding new performance growth momentum.

Comin pointed out that approximately 300,000 cataract surgeries are performed in Taiwan every year. As the aging population of the country accelerates, the demand for surgical equipment and consumables will continue to grow in the future. After the new intraocular lens products are launched one after another, combined with home tonometers and follow-up implantable contact lenses, combined with existing femtosecond cataract equipment, the company's product line becomes more complete, forming a complete ophthalmic solution from cataract, refraction, home intraocular pressure care, from equipment to consumables, and steadily advancing towards the goal of being the leading brand in cataract surgery in Taiwan.